About AUCTEQ bioreactor
AUCTEQ bioreactor is a Healthcare company based in Mannheim (Germany) founded in 2018 by Valentin Kramer. Single-use bioreactors for cell culturing processes are provided. Its chief executive, as recorded, is Valentin Kramer. AUCTEQ bioreactor offers products and services including PpHoki Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is AUCTEQ Biosystems GmbH.
Company details
AUCTEQ bioreactor was founded in 2018 and is based in Mannheim, Germany. Operations focus on the biopharmaceutical sector, where single-use bioreactors are supplied for eukaryotic cell suspensions and scale-up processes. Minimal steps are incorporated to reduce contamination risks during cell expansion. Applications include biopharmaceutical production and research activities.
- Headquarters Mannheim, Germany
- Founders Valentin Kramer
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aucteq.com
- Social LinkedIn X
- Legal Name Aucteq Biosystems Gmbh
- Latest Funding Round$56.17K (USD), Grant
Jun 2019
- Investors
Products & Services of AUCTEQ bioreactor
AUCTEQ bioreactor offers a comprehensive portfolio of products and services, including PpHoki Platform.
Platform for accessing secure educational and news content
Funding Insights of AUCTEQ bioreactor
- Total Rounds 1
- Last Round Grant — $56,170
- First Round $56,170
(Jun 2019)
- Investors Count 1
All 1 funding rounds of AUCTEQ bioreactor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $56,170 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in AUCTEQ bioreactor
AUCTEQ bioreactor has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIT Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany |
Investor details for AUCTEQ bioreactor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AUCTEQ bioreactor
1 people are tracked at AUCTEQ bioreactor (1 in leadership).
| Name | Role | Group |
|---|---|---|
Valentin Kramer | Founder & CEO | Leadership |
Complete people profiles for AUCTEQ bioreactor
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AUCTEQ bioreactor
2 dated milestones of AUCTEQ bioreactor across 1 years, from founding to its latest funding, stage changes and deals.
- Founded AUCTEQ bioreactor is founded.
- Funding First funding round of $56K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AUCTEQ bioreactor
AUCTEQ bioreactor was founded in 2018 and raised its 1st funding round 1 year after it was founded.
AUCTEQ bioreactor is headquartered in Mannheim, Germany. It is registered at Mannheim, Baden-wurttemberg, Germany.
Valentin Kramer is the CEO of AUCTEQ bioreactor, as recorded in our data. They have also founded this company.
AUCTEQ bioreactor was founded in 2018 and is based in Mannheim, Germany. Operations focus on the biopharmaceutical sector, where single-use bioreactors are supplied for eukaryotic cell suspensions and scale-up processes. Minimal steps are incorporated to reduce contamination risks during cell expansion. Applications include biopharmaceutical production and research activities.
AUCTEQ bioreactor offers PpHoki Platform.
AUCTEQ bioreactor has 1 investor. Key investors include EIT Health.
AUCTEQ bioreactor operates through Aucteq Biosystems Gmbh.